Drug intelligence / Profile preview

phosphatidylserine liposome

Development stage
Preclinical
Lead developer
Universidade Estadual de Ponta Grossa
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Intratumoral
01

Overview

Phosphatidylserine liposomes are specialized lipid-based nanoparticles composed of the phospholipid phosphatidylserine (PS). These liposomes are designed to mimic the surface of apoptotic cells, which naturally expose PS as an "eat-me" signal to trigger phagocytosis by macrophages and other phagocytes through phosphatidylserine receptors. In oncology research, PS liposomes are utilized both as standalone agents to modulate the tumor microenvironment and as delivery vehicles for therapeutic payloads, such as 7-ketocholesterol (7KC). While empty PS liposomes have been observed to potentially promote tumor growth in some models by inducing an immunosuppressive environment, loaded versions like PS/7KC are being investigated for their ability to inhibit tumor growth in melanoma and breast adenocarcinoma by inducing autophagy and altering macrophage activity.

Other names
phosphatidylserine-based liposome
02

Targets

TIMs (T-cell immunoglobulin and mucin domain-containing family receptors)TIM-1 (T-cell immunoglobulin and mucin domain-containing protein 1)CD36 (CD36 antigen)MARCOTIMD4 (T-cell immunoglobulin and mucin domain-containing protein 4)SCARB1 (Scavenger receptor class B member 1)

Beyond the preview

Go deeper on phosphatidylserine liposome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphatidylserine liposome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call